Immunotherapy Toxicities Nursing Tumor Board-Video Recording

Video Transcription

Video Summary

The video transcript discusses a case study of a 43-year-old patient with stage 4A squamous cell cervical cancer, focusing on her treatment journey and the management of side effects. Initially treated with induction chemotherapy and pembrolizumab, the patient later developed joint issues due to immunotherapy, which limited her daily activities. The discussion centers on distinguishing symptoms attributable to menopause from treatment-related side effects. The group explores the significance of systematic assessment tools like the CTCAE and highlights the importance of interdisciplinary collaboration for managing complex cases. Various healthcare professionals shared insights on handling and mitigating adverse effects, especially regarding menopausal symptoms and arthritis caused by immunotherapy. The necessity of effective communication between healthcare providers and the possibility of using alternative formulations due to shortages in menopause replacement therapy were key points covered. The video exemplifies the need for proper patient education and structured assessment to enhance the quality of life for patients undergoing cancer treatment. Furthermore, the session promotes a collaborative approach in gynecological cancer care and highlights opportunities for ongoing education and case discussions among nursing professionals.

Keywords

cervical cancer

immunotherapy

side effects

menopausal symptoms

interdisciplinary collaboration

patient education

CTCAE

gynecological cancer care